-Andrew P Mazar Researcher Activity Profile

Research Author Detailed Information 

Andrew P Mazar Publication Rate By Year

Andrew P Mazar has published 1 paper(s) in 2006, 4 paper(s) in 2007, 4 paper(s) in 2008, for a total of 9 research publications in total.

Andrew P Ap Mazar Author Information

LAST NAME: mazar

FIRST NAME: Andrew P

INITIALS: ap

AFFILIATION:

Papers

Andrew P Mazar's Publication Record

1. Differential angiogenic regulation of experimental colitis. Year Published: 2006
Department of Pathology, LSU Health Sciences Center-Shreveport, 1501 Kings Highway, Shreveport, LA 71130, USA.
2. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Year Published: 2007
Division of Gastroenterology, Istituto Clinico Humanitas, Rozzano, Milan 20089, Italy. sdanese@hotmail.com
3. Evaluating distant metastases in breast cancer: from biology to outcomes. Year Published: 2007
Department of Medicine, McGill University Health Centre, Montreal, QC, Canada, shafaat.rabbani@mcgill.ca.
4. Evaluating distant metastases in breast cancer: from biology to outcomes. Year Published: 2007
Department of Medicine, McGill University Health Centre, Montreal, QC, Canada. shafaat.rabbani@mcgill.ca
5. Evaluating distant metastases in breast cancer: from biology to outcomes. Year Published: 2007
Department of Medicine, McGill University Health Centre, Montreal, QC, Canada. shafaat.rabbani@mcgill.ca
6. Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224). Year Published: 2008
1Attenuon, LLC, San Diego, CA 92121, USA.
7. Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth. Year Published: 2008
Authors' Affiliations: Attenuon, LLC, San Diego, California.
8. Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224). Year Published: 2008
Attenuon, LLC, San Diego, CA 92121, USA. donate@attenuon.com
9. Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Year Published: 2008
Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.